XOMA Corp (XOMA)
25.51
-0.15
(-0.58%)
USD |
NASDAQ |
May 17, 16:00
25.34
-0.17
(-0.67%)
After-Hours: 20:00
XOMA SG&A Expense (Quarterly): 8.461M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.461M |
December 31, 2023 | 7.265M |
September 30, 2023 | 6.368M |
June 30, 2023 | 5.777M |
March 31, 2023 | 6.196M |
December 31, 2022 | 7.571M |
September 30, 2022 | 4.794M |
June 30, 2022 | 5.71M |
March 31, 2022 | 5.116M |
December 31, 2021 | 5.538M |
September 30, 2021 | 4.255M |
June 30, 2021 | 3.927M |
March 31, 2021 | 6.741M |
December 31, 2020 | 3.673M |
September 30, 2020 | 3.212M |
June 30, 2020 | 3.557M |
March 31, 2020 | 6.358M |
December 31, 2019 | 4.293M |
September 30, 2019 | 5.821M |
June 30, 2019 | 4.949M |
March 31, 2019 | 5.939M |
December 31, 2018 | 4.327M |
September 30, 2018 | 4.657M |
June 30, 2018 | 4.411M |
March 31, 2018 | 5.168M |
Date | Value |
---|---|
December 31, 2017 | 6.712M |
September 30, 2017 | 7.255M |
June 30, 2017 | 5.203M |
March 31, 2017 | 5.167M |
December 31, 2016 | 5.184M |
September 30, 2016 | 4.053M |
June 30, 2016 | 4.779M |
March 31, 2016 | 4.305M |
December 31, 2015 | 4.707M |
September 30, 2015 | 5.632M |
June 30, 2015 | 5.06M |
March 31, 2015 | 5.22M |
December 31, 2014 | 4.098M |
September 30, 2014 | 5.354M |
June 30, 2014 | 5.16M |
March 31, 2014 | 5.254M |
December 31, 2013 | 5.048M |
September 30, 2013 | 5.225M |
June 30, 2013 | 4.081M |
March 31, 2013 | 4.124M |
December 31, 2012 | 3.947M |
September 30, 2012 | 4.672M |
June 30, 2012 | 3.567M |
March 31, 2012 | 4.679M |
December 31, 2011 | 5.235M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.212M
Minimum
Sep 2020
8.461M
Maximum
Mar 2024
5.479M
Average
5.624M
Median
SG&A Expense (Quarterly) Benchmarks
Societal CDMO Inc (DELISTED) | 5.781M |
AbbVie Inc | 3.315B |
AnaptysBio Inc | 12.34M |
Kinnate Biopharma Inc (DELISTED) | 5.734M |
NovaBay Pharmaceuticals Inc | 3.346M |